Since GQD significantly decreased the levels of inflammatory factors, especially endotoxin and CRP, and showed more effective reduction of IL-1β, TNF-α, and MCP-1 than Met, it has good potential to protect against the progress of DM. This evidence concerns the gene CCL2 and diabetes mellitus.